Antifungal Treatment and Prevention
Recommended Therapies
- Amphotericin B is recommended for highly resistant cases by the Centers for Disease Control and Prevention 1
- Nystatin suspension (100,000 U/mL, 4-6 mL four times daily) or nystatin pastilles (200,000 U each, four times daily) for 7-14 days is recommended for mild oropharyngeal candidiasis by the Infectious Diseases Society of America 2
- Clotrimazole is a first-line treatment option for vulvovaginal candidiasis and oral thrush in patients with mild disease, with a strong recommendation, and can be applied as 1% cream intravaginally daily for 7-14 days or used as clotrimazole troches at 10mg 5 times daily for 7-14 days 3, 4
- Fluconazole (100-200 mg daily for 7-14 days) is recommended for moderate to severe oral thrush in adults by the Infectious Diseases Society of America and the American College of Physicians 5, 4, 6, 7
- Alternative treatment options for fluconazole-refractory cases include itraconazole solution, posaconazole suspension, and voriconazole, as recommended by the Infectious Diseases Society of America and the European Society of Clinical Microbiology and Infectious Diseases 5, 4, 8, 7
- Echinocandins (micafungin, caspofungin, and anidulafungin) can be used for refractory cases, with specific dosing regimens, including parenteral administration, as suggested by the European Society of Clinical Microbiology and Infectious Diseases and the Infectious Diseases Society of America 5, 4
Prevention and Prophylaxis
- Oral nystatin is recommended for oral and esophageal Candida prophylaxis in kidney transplant recipients for 1-3 months after transplantation by the American Society of Transplantation 9
- Good oral hygiene practices, including removing and cleaning dentures daily, rinsing mouth after using inhaled corticosteroids, avoiding unnecessary antibiotics, and controlling underlying conditions, are recommended to prevent oral thrush by the Infectious Diseases Society of America and the British Thoracic Society 4, 10
- Thorough disinfection of dentures is essential for patients with dentures, as part of overall treatment strategy, as recommended by the Infectious Diseases Society of America 8
Treatment Monitoring and Maintenance
- Clinical response should be evaluated within 3-5 days of treatment initiation, and monitoring liver function tests is recommended if treatment extends beyond 7-10 days, as suggested by the American College of Physicians and the IDSA 2, 11
- Prolonged use of azoles can increase the risk of resistance, especially in immunocompromised patients, and antifungal susceptibility testing can be useful in predicting clinical response to fluconazole and itraconazole in refractory cases, as recommended by the Infectious Diseases Society of America 4, 6
- Immunocompromised patients may require longer treatment durations and maintenance therapy to prevent relapse, as recommended by the Centers for Disease Control and Prevention 1
- Suppressive therapy with fluconazole (100-200 mg three times weekly) can be considered for frequent or severe recurrences, but long-term azole use increases the risk of resistance development, especially with low immune cell counts 5, 4, 6
Additional Considerations
- Optimizing blood glucose management is crucial for overall health, as recommended by the American Diabetes Association 6
- Bland mouth rinses using ingredients such as sodium bicarbonate can be used for mucositis prevention, and magic mouthwash formulations may include local anesthetics to treat pain associated with mucositis, with effectiveness varying significantly based on ingredients, as recommended by the National Comprehensive Cancer Network 12
- Rinsing the mouth after using inhaled corticosteroids can help prevent recurrence of oral thrush, with a strength of evidence supported by clinical trials, as suggested by the British Thoracic Society 10